Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Value Investing -- Ignore unavailable to you. Want to Upgrade?

To: Spekulatius who wrote (33188)	1/3/2009 1:54:38 AM
From: Paul Senior	Read Replies (1) \| Respond to of 78614

ESRX. Yes, earnings estimates for a large number of stocks may be coming down, so ESRX p/e of 15 might be decent. Analysts seem confident of ESRX's earnings. I'm following a bunch of health care stocks. Where there are Yahoo estimates, only one has forward p/e as high as 15. If the estimate p/e for ESRX is found to be correct, I'd like to believe that at least some of the stocks that I'm involved with will hold up with their estimated p/e's too. Lot of correlation in the sector. For example this year even with COV and ESRX: finance.yahoo.com If this correlation continues -- it might or might not - then if ESRX does okay, I'll be okay with COV's performance too then. Different ideas/approaches. For me, here, I'd rather try to up my COV position than start anew with ESRX.